Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram

New Technology 100% Radiation-Free

ALBUQUERQUE, N.M.--(HSMN NewsFeed)--Manhattan Scientifics, Inc. (OTCBB: MHTX ) announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.

When fully developed and commercialized, Dr. Flynn's biomagnetic-based system will be 100% radiation free, unlike current radiation-based mammogram tests. Manhattan Scientifics is currently seeking a partner to commercialize the technology.

Full text >>